When it comes to weight loss drugs, Ozempic has become a phenomenon. With nearly $14 billion sales in 2023, it shows no signs ...

Novo Nordisk is gradually ending production of human insulin pens, the drugmaker told Reuters, as it spends billions to ramp ...

About 1 in 8 U.S. adults have taken Ozempic or similar medications used to treat Type 2 diabetes and obesity. While these ...

Researchers at the University of Copenhagen have developed a new weight-loss drug that may surpass the effectiveness of ...

It’s hard to watch the news or scroll through social media without encountering stories about weight loss drugs like ...

Artemis Bayandor from Illinois in the US lost over a stone after starting to take game-changing weight-loss jabs, but like ...

The type 2 diabetes medication Ozempic has been hugely popular when prescribed off ... But between shortages, high out of ...

Better known by Novo Nordisk's brand names Ozempic and Wegovy (the former of which is indicated only for type 2 diabetes), ...

GLP-1 receptor agonists, originally developed for managing type 2 diabetes, have rapidly emerged as highly effective ...

Since semaglutide was approved by the FDA for weight loss under the brand name Wegovy in 2021, GLP-1 medications—originally ...

Company behind weight loss drug Mounjaro, Lilly, has issued an official statement after British woman, Susan McGowan, died ...

Medications such as semaglutide (branded as Ozempic and Wegovy) and tirzepatide (branded as ... Compared to liraglutide, ...